Skip to main content
Top

Current Infectious Disease Reports

Issue 5/2015

Content (7 Articles)

Central Nervous System Infections (J Lyons, Section Editor)

Neurosyphilis Update: Atypical is the New Typical

Salman Bhai, Jennifer L. Lyons

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Ebola Virus Disease: History, Epidemiology and Outbreaks

Jacqueline Weyer, Antoinette Grobbelaar, Lucille Blumberg

Pediatric Infectious Diseases (I Brook, Section Editor)

Challenges in the Management of Acute Mastoiditis in Children

Sofia Kordeluk, Mordechai Kraus, Eugene Leibovitz

Pediatric Infectious Diseases (I Brook, Section Editor)

Acute Otitis Media in Children—Current Treatment and Prevention

Marie Gisselsson-Solen

Genitourinary Infections (J Sobel, Section Editor)

Rituximab Causing Deep Ulcerative Suppurative Vaginitis/Pyoderma Gangrenosum

Priya Selva-Nayagam, Gayle Fischer, Ian Hamann, Jack Sobel, Craig James

Genitourinary Infections (J Sobel, Section Editor)

Selecting Anti-Microbial Treatment of Aerobic Vaginitis

Gilbert G. G. Donders, Katerina Ruban, Gert Bellen

Transplant and Oncology (M Ison and N Theodoropoulos, Section Editors)

Infectious Complications of Pancreatic Islet Transplantation: Clinical Experience and Unanswered Questions

Stephanie M. Pouch

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine